Literature DB >> 28031570

Alzheimer amyloid hypothesis lives on.

Asher Mullard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28031570     DOI： 10.1038/nrd.2016.281

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  12 in total

1.  A Novel Compound YS-5-23 Exhibits Neuroprotective Effect by Reducing β-Site Amyloid Precursor Protein Cleaving Enzyme 1's Expression and H2O2-Induced Cytotoxicity in SH-SY5Y Cells.

Authors:  Chen Cheng; Nan Zheng; Deyang Sun; Weishuo Fang; Lingling Zheng; Weihong Song; Jian Huang
Journal:  Neurochem Res       Date:  2020-06-18       Impact factor: 3.996

2.  A large pragmatic trial is the right solution for testing anti-amyloid therapies for Alzheimer's disease.

Authors:  M Maria Glymour; Vincent Mor
Journal:  J Am Geriatr Soc       Date:  2022-02-14       Impact factor: 7.538

3.  Neuroprotective effect of naturally occurring RXR agonists isolated from Sophora tonkinensis Gagnep. on amyloid-β-induced cytotoxicity in PC12 cells.

Authors:  Wei Wang; Ken-Ichi Nakashima; Takao Hirai; Makoto Inoue
Journal:  J Nat Med       Date:  2018-10-30       Impact factor: 2.343

4.  Electroacupuncture ameliorates beta-amyloid pathology and cognitive impairment in Alzheimer disease via a novel mechanism involving activation of TFEB (transcription factor EB).

Authors:  Xiaoyan Zheng; Wenjia Lin; Yimin Jiang; Kejia Lu; Wenjing Wei; Qingwei Huo; Shaoyang Cui; Xifei Yang; Min Li; Nenggui Xu; Chunzhi Tang; Ju-Xian Song
Journal:  Autophagy       Date:  2021-02-23       Impact factor: 16.016

Review 5.  In situ activation of therapeutics through bioorthogonal catalysis.

Authors:  Wenjie Wang; Xianzhi Zhang; Rui Huang; Cristina-Maria Hirschbiegel; Huaisong Wang; Ya Ding; Vincent M Rotello
Journal:  Adv Drug Deliv Rev       Date:  2021-07-29       Impact factor: 17.873

6.  Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β.

Authors:  Joseph W Arndt; Fang Qian; Benjamin A Smith; Chao Quan; Krishna Praneeth Kilambi; Martin W Bush; Thomas Walz; R Blake Pepinsky; Thierry Bussière; Stefan Hamann; Thomas O Cameron; Paul H Weinreb
Journal:  Sci Rep       Date:  2018-04-23       Impact factor: 4.379

7.  Cajaninstilbene Acid Ameliorates Cognitive Impairment Induced by Intrahippocampal Injection of Amyloid-β1-42 Oligomers.

Authors:  Li-Sha Wang; Xue Tao; Xin-Min Liu; Yun-Feng Zhou; Meng-Di Zhang; Yong-Hong Liao; Rui-Le Pan; Qi Chang
Journal:  Front Pharmacol       Date:  2019-09-24       Impact factor: 5.810

8.  Tailoring Peptide Self-Assembly and Formation of 2D Nanoribbons on Mica and HOPG Surface.

Authors:  Hao Kong; Bin Liu; Guozheng Yang; Yun Chen; Gang Wei
Journal:  Materials (Basel)       Date:  2022-01-02       Impact factor: 3.623

Review 9.  Norovirus Capsid Protein-Derived Nanoparticles and Polymers as Versatile Platforms for Antigen Presentation and Vaccine Development.

Authors:  Ming Tan; Xi Jiang
Journal:  Pharmaceutics       Date:  2019-09-12       Impact factor: 6.321

10.  Comparative functional genomic analysis of Alzheimer's affected and naturally aging brains.

Authors:  Yi-Shian Peng; Chia-Wei Tang; Yi-Yun Peng; Hung Chang; Chien-Lung Chen; Shu-Lin Guo; Li-Ching Wu; Min-Chang Huang; Hoong-Chien Lee
Journal:  PeerJ       Date:  2020-03-20       Impact factor: 2.984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.